Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ImmunoCellular Therapeutics Ltd (NYSE MKT LLC:IMUC)

0.2144
Delayed Data
As of Feb 11
 -0.0016 / -0.74%
Today’s Change
0.20
Today|||52-Week Range
0.71
-39.66%
Year-to-Date
No recent news for ImmunoCellular Therapeutics Ltd.

Today’s Trading

Previous close0.22
Today’s open0.22
Day’s range0.21 - 0.22
Volume55,348
Average volume (3 months)398,287
Market cap$19.5M
Dividend yield--
Data as of 3:59pm ET, 02/11/2016

Growth & Valuation

Earnings growth (last year)0.00%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book0.59

Competitors

 Today’s
change
Today’s
% change
OPGNOpGen Inc+0.09+5.70%
HTGMHTG Molecular Diagno...+0.21+9.03%
ABACAoxin Tianli Group I...-0.06-9.15%
BASIBioanalytical System...-0.09-5.76%
Data as of 3:59pm ET, 02/11/2016

Financials

Next reporting dateMarch 1, 2016
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$0.00
Annual profit (last year)-$9.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Andrew Gengos
Chief Accounting Officer &
Vice President-Finance
David E. Fractor
Corporate headquarters
Calabasas, California

Forecasts

Partner Offers